Evidence from current studies suggests that PON2 regulation involves oncogenic signalling pathways such as PI3K/Akt/IKK/NF-κB and tumour suppressors like p53 (Nagarajan et al. 2017; Que et al. 2022), yet a systematic understanding of these networks remains incomplete. This evidence concerns the gene TP53 and neoplasm.